Molecular Imaging Market – Insights
Molecular imaging technology is used for characterization and measurement of biological processes at the cellular and molecular level by using imaging detectors. Molecular imaging offers more personalized approach to evaluation and management of cardiovascular disease conditions, such as atherosclerosis, heart failure, ischemic injury, thrombosis, and left ventricular remodeling. The technology has become an integral part of standard care for many types of cancer including breast, lung, and gastrointestinal cancer.
Majority of the molecular imaging procedures involve an imaging device and an imaging agent or probe. A variety of imaging agents are used to visualize cellular activity, such as the blood flow, oxygen use, and chemical processes involved in metabolism. In nuclear medicine, a branch of molecular imaging, radiotracer is used as an imaging agent that include a radioactive atom or isotope. Other molecular imaging modalities, such as optical imaging and molecular ultrasound, use a variety of different agents. Magnetic resonance spectroscopy is able to measure chemical levels in the body, without the use of an imaging agent.
The global molecular imaging market was valued at US$ 3.8 billion in 2017, and is expected to witness a CAGR of 8.1% over the forecast period (2018 – 2026).
Global Molecular Imaging Market Value (US$ Bn) & Y-o-Y Growth (%)
Source: Coherent Market Insights Analysis (2018)
Increasing incidence of cancer, cardiovascular, and neurological diseases are expected to drive the molecular imaging market growth
Increasing incidence of various diseases such as cardiovascular, cancer, inflammatory, and neurological diseases are propelling demand for molecular imaging and is expected to drive the molecular imaging market growth during the forecast period. These diseases are becoming increasingly prevalent with rising percentage of geriatric population worldwide. According to the American Heart Association 2015 data, in the U.S., around 2 million people die due to cancer and cardiovascular disease annually.
Medical imaging is used for the early diagnosis and management of these diseases. For instance, for solid tumors, novel molecular imaging modalities such as Ultrasound, PET-CT, and MRI can facilitate earlier and more accurate diagnosis and staging, which are requisites for successful surgical therapy. Molecular imaging also plays an important role in dementia evaluation. According to the Society of Nuclear Medicine and Molecular Imaging, researchers are exploring the use of additional neuroimaging probes, including FDDNP and amyloid markers, to visualize abnormal plaques and tangles associated with Alzheimer’s disease.
Molecular Imaging Market Restraints
However, there are some limitations associated with all molecular imaging modalities, which may restrain molecular imaging market growth. For instance, optical imaging lacks penetration depth, especially when working at visible wavelengths. Depth of penetration is used for the absorption and scattering of light to identify molecular structure. Moreover, optical imaging and ultrasound do not offer whole body imaging. MRI offers unlimited depth penetration and whole body imaging, however, it is more costly than other modalities. PET-CT imaging is not recommended for all patients due to harmful radiation that causes side effects to the body. For instance, it is not suitable for pregnant women, as the radiation could harm the baby.
Molecular Imaging Market - Regional Insights
On the basis of region, the global molecular imaging market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America molecular imaging market is expected to foresee major revenue share, owing to well established healthcare infrastructure that offers all the molecular imaging modalities in various parts of the region. Moreover, increasing awareness among people about health coupled with prevalence of various diseases including cardiovascular, cancer, brain disorders is propelling demand for molecular imaging in the region.
According to the Alzheimer’s Association, in 2017, over 5 million people were suffering from Alzheimer’s disease, which is also reported to be the sixth-leading cause of death in the U.S. According to Center for Disease Control (CDC), 2016, around 610,000 deaths were reported in the U.S. annually due to cardiac arrest and other cardiovascular diseases. This rate could be lowered with proper diagnostic and imaging technologies leading to opportunities for molecular imaging market growth.
Asia Pacific molecular imaging market is anticipated to grow at highest CAGR, owing to increasing healthcare funding from government and private organizations to develop technologically advanced medical systems to fulfil demand of increasing population suffering from various diseases. Moreover, trends such as an increasing aging population, urbanization and chronic diseases underpin the demand for improved diagnostic care in the region. According to International Association of Cancer Registries, in 2012, over 600,000 new breast cancer cases were reported in Asia, accounting for 39% of all breast cancers diagnosed worldwide.
Global Molecular Imaging Market Share 2017 (%), By Region
Source: Coherent Market Insights Analysis (2018)
Molecular Imaging Market - Competitive Landscape
Key players operating in the global molecular imaging market include Carestream Health, Fujifilm Holdings Corporation, GE Healthcare, Hitachi Ltd, Hologic, Inc., Siemens AG, Philips Healthcare, Samsung Medison, Shimadzu Corporation, and Toshiba Medical Systems Corporation. Several players operating in the medical imaging devices market are focusing on improving the image quality, in order to cater to unmet medical imaging needs.
Molecular imaging is a technique used to study cellular and molecular processes in order to detect and diagnose complex molecular mechanisms, molecular changes, and gene expression present in the course of the disease. Molecular imaging includes the field of nuclear medicine, which use traces of radioactive materials (radiopharmaceuticals) to diagnose and treat disease. Molecular imaging provide information that is unreachable with other imaging technologies or that would require more invasive procedures such as surgery or biopsy. Moreover, it identify disease in its initial stages and determine the exact location of a tumor, often before symptoms occur or abnormalities can be detected with other diagnostic tests.
Increasing prevalence of various chronic diseases such as cancer and other genetic disorders are propelling demand for early disease diagnosis eventually driving the medical imaging market growth. According to the Centers for Disease Control and Prevention (CDC), February 2018 data, in the U.S., around 22,000 men and 9,000 women suffer from liver cancer, and around 16,000 men and 8,000 women die from liver cancer annually. Molecular imaging has become part of standard care for many types of cancer. The use of imaging techniques in early cancer detection, treatment response, and new therapy development is steadily growing and has already significantly impacted on clinical management of cancer.
Moreover, rising cases of neurological disorders such as Alzheimer’s, which can be easily detected with PET-CT scanner is also contributing to the medical imaging market growth. For instance, according to the Alzheimer’s Association, in 2017, over 5 million people were estimated to be suffering from Alzheimer’s disease, which was also reported to be the sixth-leading cause of death in the U.S. However, some limitations associated with molecular modalities including side effects of radiation and lack of penetration depth, which is expected to confine the molecular imaging market growth to some extent.
Key features of the study:
“*” marked represents similar segmentation in other categories in the respective section.
Table of Contents
*Browse 27 market data tables and 31 figures on "Molecular Imaging Market” - Global forecast to 2026”.
Finding it difficult to find the research that would cater to your business demands? Give us a chance to help you. One of our Research Consultants will connect to provide a customized solution.
Talk to our research consultant to design an exclusive report as per your research needs.
We aim to fulfil client's research demands with tailored research solutions.
We aim to provide research studies in quickest turnaround time and in a much cost effective manner.
We cover each industry from supply and demand side with an aim to provide a most holistic research study.
We strive to provide most accurate and reliable research findings in our research reports.